My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Agenus Inc. - Common Stock (NQ:AGEN)

7.850 +0.630 (+8.73%)

Streaming Delayed Price Updated: 4:00 PM EDT, Sep 18, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Agenus Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

2 Low-Priced Stocks That Could Make You Richer ↗

June 26, 2023

These two low-priced healthcare stocks could skyrocket within the next 12 months.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For June 6, 2023 ↗

June 06, 2023

Via Benzinga

Agenus (AGEN) Q1 2023 Earnings Call Transcript ↗

May 09, 2023

AGEN earnings call for the period ending March 31, 2023.

Via The Motley Fool

Agenus' Investigational Cancer Combo Therapy Shows 33% Durable Responses In Ovarian Cancer ↗

March 27, 2023

Via Benzinga

Why Agenus Stock Is Slumping This Week ↗

March 23, 2023

The biotech may have to raise capital soon.

Via The Motley Fool

Agenus (AGEN) Q4 2022 Earnings Call Transcript ↗

March 14, 2023

AGEN earnings call for the period ending December 31, 2022.

Via The Motley Fool

Why Amedisys Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

June 05, 2023

Gainers Sono Group N.V. (NYSE: SEV) shares surged 152.7% to $0.4367. Sono Group applied to Insolvency Court of Munich, Germany, to permit opening of self-administration proceeding.

Via Benzinga

These 3 Nasdaq Stocks Are on Fire Today: Here's Why ↗

April 17, 2023

A high-dollar buyout is lighting a fire underneath these three Nasdaq stocks today.

Via The Motley Fool

Why Agenus, Amarin, and Axsome Therapeutics Shares Slumped Today ↗

April 04, 2023

Macro headwinds are weighing on risk-laden biotech stocks today.

Via The Motley Fool

Earnings Preview For Agenus ↗

March 13, 2023

Via Benzinga

Looking Into Agenus's Return On Capital Employed ↗

December 05, 2022

Via Benzinga

Why Shares of Agenus Rose 12.5% on Friday ↗

December 02, 2022

Agenus presented data this week on a combination therapy.

Via The Motley Fool

Agenus (AGEN) Q3 2022 Earnings Call Transcript ↗

November 08, 2022

AGEN earnings call for the period ending September 30, 2022.

Via The Motley Fool

Why Travelers Companies Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

April 19, 2023

Gainers China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) gained 85.2% to $1.25 after the company announced the termination of its previously proposed registered direct offering.

Via Benzinga

Illumina, Seagen And Other Big Stocks Moving Higher On Monday ↗

March 13, 2023

U.S. stocks traded slightly lower, with the Nasdaq Composite dropping around 0.2% on Monday. Here are some big stocks recording gains in today’s session.

Via Benzinga

VBI Vaccines, Agenus Ink Partnership For Combination Brain Cancer Therapy ↗

October 12, 2022

Via Benzinga

Why Agenus Stock Rose 18.4% on Thursday ↗

October 06, 2022

The company's shares climbed with help from insider buying.

Via The Motley Fool

Agenus Presents Clinical Data Demonstrating Durable Responses For Colorectal Cancer Candidate ↗

January 23, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 22, 2022 ↗

December 22, 2022

Via Benzinga

7 Hot Stocks to Book Profits In Before 2023 ↗

December 19, 2022

With major macroeconomic headwinds appearing on the horizon, it’s time for investors to consider the hot stocks to book profits in.

Via InvestorPlace

Miniso Group, Monday.com And Other Big Gainers From Monday ↗

November 15, 2022

U.S. stocks closed lower on Monday, with the Dow Jones dropping more than 200 points. Here is the list of some big stocks recording gains in the previous session.

Via Benzinga

Why Infinity Pharmaceuticals Shares Tumbled Around 38%; Here Are 79 Biggest Movers From Yesterday ↗

November 15, 2022

Gainers Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) shares surged 113.8% to settle at $20.10 on Monday. Indivior PLC agreed to acquire Opiant Pharmaceuticals for $20.00 per share in cash, plus...

Via Benzinga

Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 53 Stocks Moving In Monday's Mid-Day Session ↗

November 14, 2022

Gainers Freight Technologies, Inc. (NASDAQ: FRGT) shares surged 137% to $0.4901 after analysts at Chardan Capital initiated coverage of the stock with a $2.25 price target.

Via Benzinga

360 DigiTech, HUTCHMED And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗

November 14, 2022

U.S. stock futures traded lower this morning. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

10 Best Medical Stocks Under $5 ↗

October 29, 2022

The medical industry is one of the most lucrative sectors globally, and it is one that sees the highest spending in terms of research and development, and breakthrough advances through keeping up the...

Via Talk Markets

12 Health Care Stocks Moving In Monday's After-Market Session ↗

October 10, 2022

Gainers Reshape Lifesciences (NASDAQ:RSLS) shares increased by 12.7% to $0.34 during Monday's after-market session. The market value of their outstanding shares is at $1.2 million.

Via Benzinga

Tilray Brands, Canopy Growth, Cronos Group And Other Big Gainers From Thursday ↗

October 07, 2022

U.S. stocks closed lower with the Dow Jones dropping more than 300 points on Thursday. Here is the list of some big stocks recording gains in the previous session.

Via Benzinga

7 Penny Stocks That Actually Have a Buy Rating ↗

September 19, 2022

Penny stocks are always a risky proposition. However, investors can still find penny stocks with buy ratings right now.

Via InvestorPlace

Why Cyclerion Therapeutics Shares Traded Lower By Around 38%; Here Are 70 Biggest Movers From Yesterday ↗

October 07, 2022

Gainers Green Giant Inc. (NASDAQ: GGE) jumped 161.1% to close at $1.88 after dipping 29% on Wednesday.

Via Benzinga

Why Revelation Biosciences Shares Are Trading Higher By 29%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session ↗

October 06, 2022

Gainers Statera Biopharma, Inc. (NASDAQ: STAB) rose 98% to $0.2777. Statera Biopharma was recently granted European patent number EP3206708 titled "Methods And Compositions For The Treatment Of...

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.